Conversation

Notices

1. Ars Technica (arstechnica@mastodon.social)'s status on Wednesday, 10-Jul-2024 00:50:54 JST Ars Technica

   New weight-loss and diabetes drugs linked to lower risk of 10 cancers

   For diabetes patients, GLP-1 drugs linked to lower cancer risks compared to insulin.

   https://arstechnica.com/science/2024/07/new-weight-loss-and-diabetes-drugs-linked-to-lower-risk-of-10-cancers/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social

   • Dźwiedziu (dzwiedziu@mastodon.social)'s status on Wednesday, 10-Jul-2024 01:13:37 JST Dźwiedziu

     in reply to

     @arstechnica
     As a former semaglutide enjoyer, with enormous benefits, that had to quit and couldn't start again because of shortages I can say only about those preliminaries results, that now it will be even more unavailable, more overpriced Nordisk stocks will skyrocket, and less people will have help.

     Nationalise health and pharma providers.